A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease

Clinical trial NCT01476696 · COMPLETED

Trial details

NCT number: NCT01476696
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2011-11-01
Primary completion: 2012-11-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.